EIDD-2801
Modify Date: 2024-01-16 17:08:45
EIDD-2801 structure
|
Common Name | EIDD-2801 | ||
|---|---|---|---|---|
| CAS Number | 2349386-89-4 | Molecular Weight | 329.31 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H19N3O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EIDD-2801EIDD-2801 is an orally bioavailable isopropylester prodrug of the ribonucleoside analog EIDD-1931. EIDD-2801 shows anti-influenza virus and coronaviruses activities. EIDD-2801 has the potential for seasonal and pandemic influenza treatment[1][2]. |
| Name | EIDD-2801 |
|---|---|
| Synonym | More Synonyms |
| Description | EIDD-2801 is an orally bioavailable isopropylester prodrug of the ribonucleoside analog EIDD-1931. EIDD-2801 shows anti-influenza virus and coronaviruses activities. EIDD-2801 has the potential for seasonal and pandemic influenza treatment[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | EIDD-2801 (7 mg/kg; oral; twice daily for 3.5 days) significantly reduces shed virus load and duration of fever[1]. Animal Model: Ca/09-infected female ferrets[1] Dosage: 7 mg/kg Administration: Oral; twice daily for 3.5 days Result: Shed virus load and duration of fever were significantly reduced. |
| References |
| Molecular Formula | C13H19N3O7 |
|---|---|
| Molecular Weight | 329.31 |
| Storage condition | 2-8℃ |
| Molnupiravir |